Status:
COMPLETED
Antenatal Corticoid Therapy for Late Preterm Babies
Lead Sponsor:
Instituto Materno Infantil Prof. Fernando Figueira
Conditions:
Hyaline Membrane Disease
Transient Tachypnea
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
This study aims to determine the effectiveness of antenatal corticosteroid therapy in late preterm babies. The investigators hypothesis is corticoid accelerates fetal lung maturation even after 34 wee...
Detailed Description
Late preterm babies have important morbidity when compared with term babies, with oxygen requirement and more days of hospitalization. If antenatal corticosteroid therapy is necessary for fetal lung m...
Eligibility Criteria
Inclusion
- Pregnancy between 34 and 36 weeks
- Confirmed gestational age (LMP, USG)
- Alive fetus
- Imminent risk of preterm delivery
Exclusion
- Multiple pregnancy
- Major fetal malformations
- Comproved fetal lung maturity
- Maternal or fetal indication for immediate interruption of pregnancy
- Maternal hemorrhagic syndromes (placenta previa, abruptio placenta)
- Chorioamnionitis
- Chronic use of corticosteroids
- Previous use of corticosteroids for fetal lung maturation in the current pregnancy
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00675246
Start Date
May 1 2008
End Date
May 1 2010
Last Update
June 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Materno Infantil Prof. Fernando Figueira
Recife, Pernambuco, Brazil, 50070550